Literature DB >> 24573933

Relationship of adrenomedullin expression and microvessel density and prognosis in smooth muscle tumor of uterus.

Yuan Jiang1, Xuehong Tian, Jie Yuan, Yuemei Jin, Yusong Tan.   

Abstract

The aim of this paper was to investigate the relationship between the expression of adrenomedullin (ADM) and microvessel density (MVD) and prognosis in smooth muscle tumor of uterus. The expression of ADM was detected using immunohistochemical staining in specimens from 15 normal controls, 28 cases of uterine leiomyoma (LE) and 19 cases of uterine leiomyosarcoma (LES). The MVD was assayed by immunostainting with CD34. There was a positive correlation between the ADM expression and MVD in LE and LES respectively (r s = 0.823, P < 0.01; r s = 0.793, P < 0.01). The expression of ADM in LE was statistically lower than that in LES (P < 0.05). There was a positive correlation between the ADM expression and mitotic figures in LES (P < 0.05): the more mitotic figures, the higher levels of the ADM expression and poor prognosis. The ADM is an important angiogenic factor in smooth muscle tumor of uterus. The ADM can be used as an accessory marker in estimating the malignant potency of LE and judging the prognosis of LES, and as a novel molecular target of anti-angiogenic and anticarcinogenic strategies.

Entities:  

Year:  2007        PMID: 24573933     DOI: 10.1007/s11684-007-0077-4

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  10 in total

1.  PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium.

Authors:  Y Zhao; S Hague; S Manek; L Zhang; R Bicknell; M C Rees
Journal:  Oncogene       Date:  1998-01-22       Impact factor: 9.867

2.  Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma.

Authors:  C Poncelet; F Walker; P Madelenat; A F Bringuier; J Y Scoazec; G Feldmann; E Darai
Journal:  Hum Pathol       Date:  2001-11       Impact factor: 3.466

Review 3.  Adrenomedullin: potential in physiology and pathophysiology.

Authors:  M Jougasaki; J C Burnett
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

4.  Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth.

Authors:  M K Oehler; C Norbury; S Hague; M C Rees; R Bicknell
Journal:  Oncogene       Date:  2001-05-24       Impact factor: 9.867

Review 5.  Adrenomedullin and cancer.

Authors:  E Zudaire; A Martínez; F Cuttitta
Journal:  Regul Pept       Date:  2003-04-15

6.  Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.

Authors:  S Hague; L Zhang; M K Oehler; S Manek; I Z MacKenzie; R Bicknell; M C Rees
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

7.  Expression of the adrenomedullin gene in epithelial ovarian cancer.

Authors:  K Hata; Y Takebayashi; S Akiba; R Fujiwaki; K Iida; K Nakayama; S Nakayama; M Fukumoto; K Miyazaki
Journal:  Mol Hum Reprod       Date:  2000-10       Impact factor: 4.025

Review 8.  Pathologic considerations of uterine smooth muscle tumors.

Authors:  R A Prayson; W R Hart
Journal:  Obstet Gynecol Clin North Am       Date:  1995-12       Impact factor: 2.844

9.  Adrenomedullin promotes proliferation and migration of cultured endothelial cells.

Authors:  Kazutoshi Miyashita; Hiroshi Itoh; Naoki Sawada; Yasutomo Fukunaga; Masakatsu Sone; Kenichi Yamahara; Takami Yurugi; Kazuwa Nakao
Journal:  Hypertens Res       Date:  2003-02       Impact factor: 3.872

10.  Expression of adrenomedullin in the endometrium of the human uterus.

Authors:  M Michishita; T Minegishi; K Abe; K Kangawa; M Kojima; Y Ibuki
Journal:  Obstet Gynecol       Date:  1999-01       Impact factor: 7.661

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.